Royalty Stream

Royalty Stream. Means: (i) six percent (6%) of Net Sales for all Products that are not FDA Products; (ii) seven percent (7%) of Net Sales for all FDA Products, excluding the SinuNase Formulation; and (iii) fourteen percent (14%) of Net Sales for the SinuNase Formulation. Payments of the Royalty Stream shall be made on a quarterly basis in accordance with Section 6. By way of illustration and example, if an Accentia sublicensee invoices a customer $220 for the sale of a non-FDA Product (i.e., the sublicensee's... Net Sales is $220), then the Royalty Stream on the transaction, which is payable by Accentia to PPD, would be 6% of $220 or $13.20 regardless of any royalty due Accentia from the sublicensee. View More

Royalty Stream. Means fifty percent (50%) of all Royalty Payments required to be paid by Accentia under the License Agreement. Notwithstanding the forgoing, Royalty Stream shall not include Royalty Payments that are payable by Accentia under the License Agreement that are based on the sale of products exclusively intended to treat asthma.